Clinical Characteristics and Survival Outcomes of Patients with De Novo Metastatic Breast Cancer

PURPOSE: Though less than 5% of patients with breast cancer present with De Novo Metastasis (dnMBC) in Western societies, this percentage may reach 30% in developing countries. In this study, we present survival outcomes of patients diagnosed with dnMBC treated at a tertiary center in a developing c...

Descripción completa

Detalles Bibliográficos
Autores principales: Almasri, Hanan, Erjan, Ayah, Abudawaba, Hebah, Ashouri, Khaled, Mheid, Sara, Alnsour, Anoud, Abdel-Razeq, Hikmat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9628702/
https://www.ncbi.nlm.nih.gov/pubmed/36340331
http://dx.doi.org/10.2147/BCTT.S383874

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9628702/
https://www.ncbi.nlm.nih.gov/pubmed/36340331
http://dx.doi.org/10.2147/BCTT.S383874

Ejemplares similares